Mei Pharma Inc (MEIP)

07:16 AM

Follicular Lymphoma Treatment Market 2034: EMA, PDMA, FDA Approval, Clinical Trials, Medication, Prevalence, Revenue, Statistics and Companies by DelveInsight - The Globe and Mail

07:16 AM

Apr 16, 2025

MEI Pharma (NASDAQ:MEIP) Stock Passes Below Two Hundred Day Moving Average – Here’s What Happened - Defense World

Apr 16, 2025

Apr 16, 2025

StockNews.com Initiates Coverage on MEI Pharma (NASDAQ:MEIP) - Defense World

Apr 16, 2025

Apr 09, 2025

MEI Pharma stock hits 52-week low at $1.83 amid market challenges - Investing.com

Apr 09, 2025

Apr 08, 2025

MEI Pharma stock hits 52-week low at $1.83 amid market challenges By Investing.com - Investing.com South Africa

Apr 08, 2025

Apr 08, 2025

MEI Pharma (NASDAQ:MEIP) Coverage Initiated at StockNews.com - Defense World

Apr 08, 2025

Apr 04, 2025

MEI PHARMA INC- The GF Score's 5 Key Aspects of Analysis - GuruFocus

Apr 04, 2025

Apr 02, 2025

Follicular Lymphoma Market to Reach New Heights in Growth - openPR.com

Apr 02, 2025

Apr 02, 2025

Follicular Lymphoma Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Roche, BeiGene, Kite Pharma, Incyte Corp, AstraZeneca, MEI Pharma, Novartis, Innovent Biologics, Regeneron - Barchart.com

Apr 02, 2025

Apr 02, 2025

Virtu Financial LLC Purchases Shares of 10,744 MEI Pharma, Inc. (NASDAQ:MEIP) - Defense World

Apr 02, 2025

Apr 01, 2025

MEI Pharma (NASDAQ:MEIP) Now Covered by Analysts at StockNews.com - The AM Reporter

Apr 01, 2025

Mar 31, 2025

StockNews.com Begins Coverage on MEI Pharma (NASDAQ:MEIP) - Defense World

Mar 31, 2025

Mar 28, 2025

MEI Pharma stock hits 52-week low at $2.27 amid market challenges - Investing.com Australia

Mar 28, 2025

Mar 23, 2025

MEI Pharma (NASDAQ:MEIP) Coverage Initiated by Analysts at StockNews.com - Defense World

Mar 23, 2025

Mar 18, 2025

MEI Pharma stock hits 52-week low at $2.28 amid market challenges - Investing.com Australia

Mar 18, 2025

Mar 17, 2025

MEI Pharma stock hits 52-week low at $2.28 amid market challenges By Investing.com - Investing.com South Africa

Mar 17, 2025

Mar 07, 2025

MEI Pharma, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025

Mar 06, 2025

10 Cheap Chinese Stocks to Buy Now - Insider Monkey

Mar 06, 2025

Mar 05, 2025

11 Best Undervalued Stocks to Invest in Now - Insider Monkey

Mar 05, 2025

Feb 26, 2025

The Polycythemia Vera Market Landscape Heats Up Amid Rising Competition Among Pharma Companies | DelveInsight - The Malaysian Reserve

Feb 26, 2025

Feb 19, 2025

C-COM Antenna Receives Eutelsat Type Approval - The Globe and Mail

Feb 19, 2025

Feb 19, 2025

Marginal Zone Lymphoma Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies - The Globe and Mail

Feb 19, 2025

Feb 19, 2025

Alarm.com (ALRM) Q4 Earnings: What To Expect - The Globe and Mail

Feb 19, 2025

Feb 19, 2025

Why Tight Corporate-U.S. Treasury Yield Spreads Signal Good News for Ag Markets Prices - The Globe and Mail

Feb 19, 2025

Feb 13, 2025

MEI Pharma Reports Increased Losses Amid Strategic Shift - TipRanks

Feb 13, 2025

Feb 12, 2025

MEI Pharma Reports Second Quarter Fiscal Year 2025 Cash Position - BioSpace

Feb 12, 2025

Feb 12, 2025

MEI Pharma Inc. (MEIP) reports earnings - Quartz

Feb 12, 2025

Feb 12, 2025

MEI Pharma, Inc. SEC 10-Q Report - TradingView

Feb 12, 2025

Feb 10, 2025

Geriatric Population And Unmet Healthcare Needs Fuel Growth In Acute Myeloid Leukemia Market: A Key Driver ... - WhaTech

Feb 10, 2025

Feb 10, 2025

Malt Lymphoma Pipeline 2024: Detailed Clinical Trials - openPR

Feb 10, 2025

Feb 10, 2025

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives $43.60 Average Target Price from Analysts - Defense World

Feb 10, 2025

Feb 10, 2025

No Headlines, No Problem: Why Technical Analysis Still Moves Stocks - The Globe and Mail

Feb 10, 2025

Feb 07, 2025

Layoff Tracker: Viracta, X4 and BMS Detail Current, Upcoming Cuts - BioSpace

Feb 07, 2025

Feb 06, 2025

Protein Bar Launch in Convenience Channel, Sending Shares of this MicroCap Higher - The Globe and Mail

Feb 06, 2025

Feb 03, 2025

MEI Pharma (NASDAQ:MEIP) Earns Buy Rating from Analysts at StockNews.com - Defense World

Feb 03, 2025

Feb 02, 2025

3 Easy Ways to Build Up Your Portfolio in 2025 - The Globe and Mail

Feb 02, 2025

Feb 02, 2025

Scientist pleads guilty to stealing trade secrets for Chinese pharma company - Fox28 Savannah

Feb 02, 2025

Jan 30, 2025

Kimberly-Clark: A Regal Opportunity in This Dividend King - The Globe and Mail

Jan 30, 2025

Jan 27, 2025

ROSEN, A LEADING LAW FIRM, Encourages Infinity Pharmaceuticals, - GuruFocus.com

Jan 27, 2025

Jan 26, 2025

Will PepsiCo Hike Its Dividend Soon?Looks LikelyValue Investors Love the Stock - The Globe and Mail

Jan 26, 2025

Jan 26, 2025

MEI Pharma (NASDAQ:MEIP) Now Covered by StockNews.com - Defense World

Jan 26, 2025

Jan 21, 2025

Assenagon Asset Management S.A. Buys 2,285 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) - Defense World

Jan 21, 2025

Jan 15, 2025

B-cell Non-hodgkin Lymphoma Clinical and Non-Clinical - openPR

Jan 15, 2025